Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Tetrandrine inhibits hepatocellular carcinoma cell growth through the caspase pathway and G2/M phase
by
YU, VIVIAN W.L
, HO, WING SHING
in
Antineoplastic Agents, Phytogenic - pharmacology
/ Apoptosis
/ Benzylisoquinolines - pharmacology
/ cancer
/ Cancer therapies
/ Carcinoma, Hepatocellular - drug therapy
/ Caspase 9 - metabolism
/ cell cycle
/ Cell growth
/ Cell Line, Tumor - drug effects
/ Cell Survival - drug effects
/ Cyclin-Dependent Kinase Inhibitor p21 - metabolism
/ Enzyme Activation - drug effects
/ G2 Phase Cell Cycle Checkpoints - drug effects
/ Huh-7
/ Humans
/ inhibition
/ Inhibitory Concentration 50
/ Liver cancer
/ Liver Neoplasms - drug therapy
/ Signal Transduction
/ tetrandrine
2013
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Tetrandrine inhibits hepatocellular carcinoma cell growth through the caspase pathway and G2/M phase
by
YU, VIVIAN W.L
, HO, WING SHING
in
Antineoplastic Agents, Phytogenic - pharmacology
/ Apoptosis
/ Benzylisoquinolines - pharmacology
/ cancer
/ Cancer therapies
/ Carcinoma, Hepatocellular - drug therapy
/ Caspase 9 - metabolism
/ cell cycle
/ Cell growth
/ Cell Line, Tumor - drug effects
/ Cell Survival - drug effects
/ Cyclin-Dependent Kinase Inhibitor p21 - metabolism
/ Enzyme Activation - drug effects
/ G2 Phase Cell Cycle Checkpoints - drug effects
/ Huh-7
/ Humans
/ inhibition
/ Inhibitory Concentration 50
/ Liver cancer
/ Liver Neoplasms - drug therapy
/ Signal Transduction
/ tetrandrine
2013
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Tetrandrine inhibits hepatocellular carcinoma cell growth through the caspase pathway and G2/M phase
by
YU, VIVIAN W.L
, HO, WING SHING
in
Antineoplastic Agents, Phytogenic - pharmacology
/ Apoptosis
/ Benzylisoquinolines - pharmacology
/ cancer
/ Cancer therapies
/ Carcinoma, Hepatocellular - drug therapy
/ Caspase 9 - metabolism
/ cell cycle
/ Cell growth
/ Cell Line, Tumor - drug effects
/ Cell Survival - drug effects
/ Cyclin-Dependent Kinase Inhibitor p21 - metabolism
/ Enzyme Activation - drug effects
/ G2 Phase Cell Cycle Checkpoints - drug effects
/ Huh-7
/ Humans
/ inhibition
/ Inhibitory Concentration 50
/ Liver cancer
/ Liver Neoplasms - drug therapy
/ Signal Transduction
/ tetrandrine
2013
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Tetrandrine inhibits hepatocellular carcinoma cell growth through the caspase pathway and G2/M phase
Journal Article
Tetrandrine inhibits hepatocellular carcinoma cell growth through the caspase pathway and G2/M phase
2013
Request Book From Autostore
and Choose the Collection Method
Overview
Activation of p53-independent pathways plays an important role in phytochemical-induced apoptosis and is considered to be a crucial factor in the invasion and metastasis of cancer. Previous studies have shown that combined effects of Stephania tetrandra with medicinal herbs exhibit beneficial effects in cancer patients. Tetrandrine, an active component of Stephania tetrandra has been reported to have anticancer properties in cancer cells. However, the mechanism(s) of action of tetrandrine in liver cancer have yet to be fully elucidated. In this study, we investigated the effects of tetrandrine in hepatocellular carcinoma (HCC) cells. The results showed that tetrandrine inhibited HCC cell proliferation by suppression of cell cycle progression at the G2/M phase. Changes in the expression levels of Bax, Bcl, p53, survivin, PCNA, PARP and p21 were observed. In addition, tetrandrine increased caspase-3 expression and induced DNA fragmentation in Huh-7 cells. The results suggest that the anti-cancer effect of tetrandrine in Huh-7 cells may be mediated by p53-independent pathways.
Publisher
D.A. Spandidos,Spandidos Publications UK Ltd
Subject
Antineoplastic Agents, Phytogenic - pharmacology
/ Benzylisoquinolines - pharmacology
/ cancer
/ Carcinoma, Hepatocellular - drug therapy
/ Cell Line, Tumor - drug effects
/ Cell Survival - drug effects
/ Cyclin-Dependent Kinase Inhibitor p21 - metabolism
/ Enzyme Activation - drug effects
/ G2 Phase Cell Cycle Checkpoints - drug effects
/ Huh-7
/ Humans
This website uses cookies to ensure you get the best experience on our website.